FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Veterinary research communications2011; 35(7); 401-408; doi: 10.1007/s11259-011-9487-5

Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis.

Abstract: The measurement of biomarkers that reflect cartilage breakdown is a powerful tool for investigating joint damage caused by disease or injury. Particularly in cases of osteochondrosis, synovial concentrations of these biomarkers may reveal the presence of osteoarthritic changes. Coll2-1, Coll2-1 NO2 and myeloperoxidase have recently been introduced in equine osteoarticular research but comparison between the concentrations of these markers in OCD affected and healthy joints has not been made. Therefore, this study aimed at reporting the synovial concentrations of these biomarkers in joints affected with osteochondral fragments in the tarsocrural joint compared to unaffected joints. Myeloperoxidase and Coll2-1NO2 revealed to have similar levels between affected joints and controls. However, in contrast to previous studies using C2C the present study demonstrated that synovial levels of Coll2-1 were significantly elevated in tarsocrural joints affected with osteochondrosis. Thus, Coll2-1 may be an earlier marker of cartilage degeneration than other cartilage degradation markers that have been previously used in equine medicine.
Get Full Text
Publication Date: 2011-06-17 PubMed ID: 21681550DOI: 10.1007/s11259-011-9487-5Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigated the presence and levels of specific proteins (Coll2-1, Coll2-1NO2, and myeloperoxidase) in the synovial fluid of horse joints affected by a cartilage disease known as osteochondrosis. It found that the levels of one protein, Coll2-1, were significantly higher in the afflicted joints, suggesting that it may be an earlier marker of cartilage degradation.

Objectives and Approach

  • The research aimed to measure and compare the concentrations of three biomarkers, namely Coll2-1, Coll2-1NO2, and myeloperoxidase, in the synovial fluid from joints suffering from osteochondrosis and healthy ones. These markers indicate the breakdown of cartilage, an essential tissue for joint health.
  • The principal impetus for this study was to enhance the understanding of osteochondrosis, a disease that triggers joint damage, particularly in horse joints. The findings could potentially improve the early detection of the disease.

Findings

  • The levels of myeloperoxidase and Coll2-1NO2 were found to be similar in both ailing and healthy joints. However, the synovial fluid from the joints affected by osteochondrosis displayed a significant rise in the concentration of Coll2-1.
  • This finding contradicts previous research that deployed another marker, C2C, to probe cartilage degradation in the same circumstance. This suggests that Coll2-1 may indeed be a more sensitive and earlier indicator of cartilage degeneration.

Implications and Future Research

  • The findings could lead to improved methods of early osteochondrosis detection. By focusing on Coll2-1 as a potential marker for cartilage break down, practitioners may be able to identify and treat osteochondrosis in its early stages.
  • The results encourage further research in this field. Future studies may need to confirm this investigation’s findings and explore other potential biomarkers for cartilage degradation. Ultimately, the objective is to implement better strategies for diagnosing and managing joint diseases like osteochondrosis, particularly in horses.

Cite This Article

APA
Verwilghen DR, Martens A, Busschers E, Franck T, Deberg M, Henrotin Y, Vanderheyden L, Serteyn D. (2011). Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis. Vet Res Commun, 35(7), 401-408. https://doi.org/10.1007/s11259-011-9487-5

Publication

Veterinary research communications
ISSN: 1573-7446
NlmUniqueID: 8100520
Country: Switzerland
Language: English
Volume: 35
Issue: 7
Pages: 401-408

Researcher Affiliations

Verwilghen, Denis R
  • Equine Clinic, Department of Companion Animals and Equids, Faculty of Veterinary Medicine of Liege, Sart-Tilman B41, 4000, Liege, Belgium. Denis.verwilghen@uds.slu.se
Martens, Ann
    Busschers, Evita
      Franck, Thierry
        Deberg, Michelle
          Henrotin, Yves
            Vanderheyden, Laurent
              Serteyn, Didier

                MeSH Terms

                • Animals
                • Biomarkers / analysis
                • Collagen Type II / analysis
                • Collagen Type II / metabolism
                • Hindlimb / metabolism
                • Horse Diseases / metabolism
                • Horses
                • Joint Diseases / metabolism
                • Joint Diseases / veterinary
                • Osteochondrosis / metabolism
                • Osteochondrosis / veterinary
                • Peptide Fragments / analysis
                • Peptide Fragments / metabolism
                • Peroxidase / analysis
                • Peroxidase / metabolism
                • Synovial Fluid / metabolism
                • Tarsal Joints / metabolism

                References

                This article includes 38 references
                1. Gangl M, Serteyn D, Lejeune JP, Schneider N, Grulke S, Peters F, Vila T, Deby-Dupont G, Deberg M, Henrotin Y. A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions.. Res Vet Sci 2007 Feb;82(1):68-75.
                  pubmed: 16780906doi: 10.1016/j.rvsc.2006.03.008google scholar: lookup
                2. Franck T, Grulke S, Deby-Dupont G, Deby C, Duvivier H, Peters F, Serteyn D. Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood.. J Vet Diagn Invest 2005 Sep;17(5):412-9.
                  pubmed: 16312231doi: 10.1177/104063870501700502google scholar: lookup
                3. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients.. FEBS Lett 1994 Aug 15;350(1):9-12.
                  pubmed: 8062931doi: 10.1016/0014-5793(94)00722-5google scholar: lookup
                4. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.. Am J Physiol 1996 Nov;271(5 Pt 1):C1424-37.
                  pubmed: 8944624doi: 10.1152/ajpcell.1996.271.5.C1424google scholar: lookup
                5. Henrotin Y, Deby-Dupont G, Deby C, De Bruyn M, Lamy M, Franchimont P. Production of active oxygen species by isolated human chondrocytes.. Br J Rheumatol 1993 Jul;32(7):562-7.
                  pubmed: 8393361doi: 10.1093/rheumatology/32.7.562google scholar: lookup
                6. Baldus S, Eiserich JP, Brennan ML, Jackson RM, Alexander CB, Freeman BA. Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases.. Free Radic Biol Med 2002 Oct 1;33(7):1010.
                  pubmed: 12361810doi: 10.1016/s0891-5849(02)00993-0google scholar: lookup
                7. Runge JJ, Biery DN, Lawler DF, Gregor TP, Evans RH, Kealy RD, Szabo SD, Smith GK. The effects of lifetime food restriction on the development of osteoarthritis in the canine shoulder.. Vet Surg 2008 Jan;37(1):102-7.
                  pubmed: 18199063doi: 10.1111/j.1532-950X.2007.00354.xgoogle scholar: lookup
                8. Garvican ER, Vaughan-Thomas A, Innes JF, Clegg PD. Biomarkers of cartilage turnover. Part 1: Markers of collagen degradation and synthesis.. Vet J 2010 Jul;185(1):36-42.
                  pubmed: 20488735doi: 10.1016/j.tvjl.2010.04.011google scholar: lookup
                9. Billinghurst RC, Brama PA, van Weeren PR, Knowlton MS, McIlwraith CW. Evaluation of serum concentrations of biomarkers of skeletal metabolism and results of radiography as indicators of severity of osteochondrosis in foals.. Am J Vet Res 2004 Feb;65(2):143-50.
                  pubmed: 14974569doi: 10.2460/ajvr.2004.65.143google scholar: lookup
                10. Laws EG, Richardson DW, Ross MW, Moyer W. Racing performance of standardbreds after conservative and surgical treatment for tarsocrural osteochondrosis.. Equine Vet J 1993 May;25(3):199-202.
                  pubmed: 8508747doi: 10.1111/j.2042-3306.1993.tb02943.xgoogle scholar: lookup
                11. Burner U, Furtmuller PG, Kettle AJ, Koppenol WH, Obinger C. Mechanism of reaction of myeloperoxidase with nitrite.. J Biol Chem 2000 Jul 7;275(27):20597-601.
                  pubmed: 10777476doi: 10.1074/jbc.M000181200google scholar: lookup
                12. Laverty S, Okouneff S, Ionescu M, Reiner A, Pidoux I, Webber C, Rossier Y, Billinghurst RC, Poole AR. Excessive degradation of type II collagen in articular cartilage in equine osteochondrosis.. J Orthop Res 2002 Nov;20(6):1282-9.
                  pubmed: 12472241doi: 10.1016/S0736-0266(02)00053-0google scholar: lookup
                13. Deberg M, Dubuc JE, Labasse A, Sanchez C, Quettier E, Bosseloir A, Crielaard JM, Henrotin Y. One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement.. Ann Rheum Dis 2008 Feb;67(2):168-74.
                  pubmed: 17644542doi: 10.1136/ard.2007.073452google scholar: lookup
                14. Henrotin Y, Addison S, Kraus V, Deberg M. Type II collagen markers in osteoarthritis: what do they indicate?. Curr Opin Rheumatol 2007 Sep;19(5):444-50.
                  pubmed: 17762609doi: 10.1097/BOR.0b013e32829fb3b5google scholar: lookup
                15. Henrotin YE, Zheng SX, Deby GP, Labasse AH, Crielaard JM, Reginster JY. Nitric oxide downregulates interleukin 1beta (IL-1beta) stimulated IL-6, IL-8, and prostaglandin E2 production by human chondrocytes.. J Rheumatol 1998 Aug;25(8):1595-601.
                  pubmed: 9712106
                16. Kuwabara K, Jyoyama H, Fleisch JH, Hori Y. Inhibition of antigen-induced arthritis in guinea pigs by a selective LTB4 receptor antagonist LY293111Na.. Inflamm Res 2002 Nov;51(11):541-50.
                  pubmed: 12540018doi: 10.1007/pl00012425google scholar: lookup
                17. Lejeune JP, Serteyn D, Gangl M, Schneider N, Deby-Dupont G, Deberg M, Henrotin Y. Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing Ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy.. Vet Res Commun 2007 Jul;31(5):591-601.
                  pubmed: 17252318doi: 10.1007/s11259-007-3518-2google scholar: lookup
                18. Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, Hotchkiss RS, Belaaouaj A, Heinecke JW. Myeloperoxidase produces nitrating oxidants in vivo.. J Clin Invest 2002 May;109(10):1311-9.
                  pubmed: 12021246doi: 10.1172/JCI15021google scholar: lookup
                19. Art T, Franck T, Gangl M, Votion D, Kohnen S, Deby-Dupont G, Serteyn D. Plasma concentrations of myeloperoxidase in endurance and 3-day event horses after a competition.. Equine Vet J Suppl 2006 Aug;(36):298-302.
                  pubmed: 17402436doi: 10.1111/j.2042-3306.2006.tb05557.xgoogle scholar: lookup
                20. Jenner F, Ross MW, Martin BB, Richardson DW. Scapulohumeral osteochondrosis. A retrospective study of 32 horses.. Vet Comp Orthop Traumatol 2008;21(5):406-12.
                  pubmed: 19011703
                21. Deberg M, Labasse A, Christgau S, Cloos P, Bang Henriksen D, Chapelle JP, Zegels B, Reginster JY, Henrotin Y. New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis.. Osteoarthritis Cartilage 2005 Mar;13(3):258-65.
                  pubmed: 15727893doi: 10.1016/j.joca.2004.12.002google scholar: lookup
                22. Huebner JL, Williams JM, Deberg M, Henrotin Y, Kraus VB. Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis.. Osteoarthritis Cartilage 2010 Mar;18(3):397-405.
                  pubmed: 19825496doi: 10.1016/j.joca.2009.09.011google scholar: lookup
                23. de Grauw JC, Brama PA, Wiemer P, Brommer H, van de Lest CH, van Weeren PR. Cartilage-derived biomarkers and lipid mediators of inflammation in horses with osteochondritis dissecans of the distal intermediate ridge of the tibia.. Am J Vet Res 2006 Jul;67(7):1156-62.
                  pubmed: 16817736doi: 10.2460/ajvr.67.7.1156google scholar: lookup
                24. Schneider N, Mouithys-Mickalad AL, Lejeune JP, Deby-Dupont GP, Hoebeke M, Serteyn DA. Synoviocytes, not chondrocytes, release free radicals after cycles of anoxia/re-oxygenation.. Biochem Biophys Res Commun 2005 Aug 26;334(2):669-73.
                  pubmed: 16036131doi: 10.1016/j.bbrc.2005.06.147google scholar: lookup
                25. Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Vadseth C, Narine L, Lenkiewicz E, Borchers MT, Lusis AJ, Lee JJ, Lee NA, Abu-Soud HM, Ischiropoulos H, Hazen SL. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species.. J Biol Chem 2002 May 17;277(20):17415-27.
                  pubmed: 11877405doi: 10.1074/jbc.M112400200google scholar: lookup
                26. Ameye LG, Deberg M, Oliveira M, Labasse A, Aeschlimann JM, Henrotin Y. The chemical biomarkers C2C, Coll2-1, and Coll2-1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice.. Arthritis Rheum 2007 Oct;56(10):3336-46.
                  pubmed: 17907187doi: 10.1002/art.22875google scholar: lookup
                27. Grulke S, Benbarek H, Caudron I, Deby-Dupont G, Mathy-Hartert M, Farnir F, Deby C, Lamy M, Serteyn D. Plasma myeloperoxidase level and polymorphonuclear leukocyte activation in horses suffering from large intestinal obstruction requiring surgery: preliminary results.. Can J Vet Res 1999 Apr;63(2):142-7.
                  pubmed: 10369573
                28. Deberg MA, Labasse AH, Collette J, Seidel L, Reginster JY, Henrotin YE. One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression.. Osteoarthritis Cartilage 2005 Dec;13(12):1059-65.
                  pubmed: 16154771doi: 10.1016/j.joca.2005.06.014google scholar: lookup
                29. Green SP, Baker MS, Lowther DA. Depolymerization of synovial fluid hyaluronic acid (HA) by the complete myeloperoxidase (MPO) system may involve the formation of a HA-MPO ionic complex.. J Rheumatol 1990 Dec;17(12):1670-5.
                  pubmed: 1964699
                30. Schiller J, Arnhold J, Sonntag K, Arnold K. NMR studies on human, pathologically changed synovial fluids: role of hypochlorous acid.. Magn Reson Med 1996 Jun;35(6):848-53.
                  pubmed: 8744012doi: 10.1002/mrm.1910350610google scholar: lookup
                31. Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, Heinegård D, Jordan JM, Kepler TB, Lane NE, Saxne T, Tyree B, Kraus VB. Classification of osteoarthritis biomarkers: a proposed approach.. Osteoarthritis Cartilage 2006 Aug;14(8):723-7.
                  pubmed: 16733093doi: 10.1016/j.joca.2006.04.001google scholar: lookup
                32. Myers SL, Brandt KD, Eilam O. Even low-grade synovitis significantly accelerates the clearance of protein from the canine knee. Implications for measurement of synovial fluid "markers" of osteoarthritis.. Arthritis Rheum 1995 Aug;38(8):1085-91.
                  pubmed: 7639804doi: 10.1002/art.1780380810google scholar: lookup
                33. Henrotin Y, Deberg M, Mathy-Hartert M, Deby-Dupont G. Biochemical biomarkers of oxidative collagen damage.. Adv Clin Chem 2009;49:31-55.
                  pubmed: 19947354doi: 10.1016/s0065-2423(09)49002-4google scholar: lookup
                34. Fietz S, Bondzio A, Moschos A, Hertsch B, Einspanier R. Measurement of equine myeloperoxidase (MPO) activity in synovial fluid by a modified MPO assay and evaluation of joint diseases - an initial case study.. Res Vet Sci 2008 Jun;84(3):347-53.
                  pubmed: 17675122doi: 10.1016/j.rvsc.2007.06.006google scholar: lookup
                35. Henrotin Y, Deberg M, Dubuc JE, Quettier E, Christgau S, Reginster JY. Type II collagen peptides for measuring cartilage degradation.. Biorheology 2004;41(3-4):543-7.
                  pubmed: 15299285
                36. Verwilghen D, Busoni V, Gangl M, Franck T, Lejeune JP, Vanderheyden L, Detilleux J, Grulke S, Deberg M, Henrotin Y, Serteyn D. Relationship between biochemical markers and radiographic scores in the evaluation of the osteoarticular status of Warmblood stallions.. Res Vet Sci 2009 Oct;87(2):319-28.
                  pubmed: 19298987doi: 10.1016/j.rvsc.2009.02.002google scholar: lookup
                37. Laverty S, Ionescu M, Marcoux M, Bouré L, Doizé B, Poole AR. Alterations in cartilage type-II procollagen and aggrecan contents in synovial fluid in equine osteochondrosis.. J Orthop Res 2000 May;18(3):399-405.
                  pubmed: 10937626doi: 10.1002/jor.1100180311google scholar: lookup
                38. Steinbeck MJ, Nesti LJ, Sharkey PF, Parvizi J. Myeloperoxidase and chlorinated peptides in osteoarthritis: potential biomarkers of the disease.. J Orthop Res 2007 Sep;25(9):1128-35.
                  pubmed: 17474133doi: 10.1002/jor.20400google scholar: lookup

                Citations

                This article has been cited 5 times.
                1. Marouf BH. Effect of Resveratrol on Serum Levels of Type II Collagen and Aggrecan in Patients with Knee Osteoarthritis: A Pilot Clinical Study. Biomed Res Int 2021;2021:3668568.
                  doi: 10.1155/2021/3668568pubmed: 34805399google scholar: lookup
                2. Bourebaba L, Röcken M, Marycz K. Osteochondritis dissecans (OCD) in Horses - Molecular Background of its Pathogenesis and Perspectives for Progenitor Stem Cell Therapy. Stem Cell Rev Rep 2019 Jun;15(3):374-390.
                  doi: 10.1007/s12015-019-09875-6pubmed: 30796679google scholar: lookup
                3. Legrand CB, Lambert CJ, Comblain FV, Sanchez C, Henrotin YE. Review of Soluble Biomarkers of Osteoarthritis: Lessons From Animal Models. Cartilage 2017 Jul;8(3):211-233.
                  doi: 10.1177/1947603516656739pubmed: 28618869google scholar: lookup
                4. Henrotin Y, Gharbi M, Dierckxsens Y, Priem F, Marty M, Seidel L, Albert A, Heuse E, Bonnet V, Castermans C. Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complement Altern Med 2014 May 17;14:159.
                  doi: 10.1186/1472-6882-14-159pubmed: 24886572google scholar: lookup
                5. Bertuglia A, Pallante M, Pagliara E, Valle D, Bergamini L, Bollo E, Bullone M, Riccio B. Determinants of joint effusion in tarsocrural osteochondrosis of yearling Standardbred horses. Front Vet Sci 2024;11:1389798.
                  doi: 10.3389/fvets.2024.1389798pubmed: 39113724google scholar: lookup
                Subscribe to our newsletter
                Join 100,127 horse owners like you who receive our email updates on horse health and nutrition.